Zobrazeno 1 - 10
of 4 001
pro vyhledávání: '"646"'
Autor:
Uwamino Y; Department of Laboratory Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan; Department of Infectious Diseases, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Kurafuji T; Clinical Laboratory, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Sato Y; Department of Preventive Medicine and Public Health, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Tomita Y; Department of Laboratory Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Shibata A; Department of Laboratory Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Tanabe A; Clinical Laboratory, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Yatabe Y; Clinical Laboratory, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Noguchi M; Clinical Laboratory, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Arai T; Clinical Laboratory, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Ohno A; Clinical Laboratory, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Yokota H; Clinical Laboratory, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Yamasawa W; Department of Laboratory Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Uno S; Department of Infectious Diseases, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Nishimura T; Health Center, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Hasegawa N; Department of Infectious Diseases, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Saya H; Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan., Wakui M; Department of Laboratory Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. Electronic address: wakuism@a6.keio.jp., Murata M; Department of Laboratory Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Publikováno v:
Vaccine [Vaccine] 2022 Feb 11; Vol. 40 (7), pp. 1019-1025. Date of Electronic Publication: 2022 Jan 07.
Autor:
Goodman KE; Department of Epidemiology and Public Health, The University of Maryland School of Medicine, Baltimore, Maryland, USA., Magder LS; Department of Epidemiology and Public Health, The University of Maryland School of Medicine, Baltimore, Maryland, USA., Baghdadi JD; Department of Epidemiology and Public Health, The University of Maryland School of Medicine, Baltimore, Maryland, USA., Pineles L; Department of Epidemiology and Public Health, The University of Maryland School of Medicine, Baltimore, Maryland, USA., Levine AR; Department of Pulmonary & Critical Care Medicine, The University of Maryland School of Medicine, Baltimore, Maryland, USA., Perencevich EN; Department of Internal Medicine and Epidemiology, The University of Iowa Carver College of Medicine, Iowa City, Iowa, USA., Harris AD; Department of Epidemiology and Public Health, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Dec 06; Vol. 73 (11), pp. e4113-e4123.
Autor:
Alasia D; Department of Internal Medicine, University of Port Harcourt, Rivers State, Nigeria., Owhonda G; Department of Public Health and Disease Control, Rivers State Ministry of Health, Rivers State, Nigeria., Maduka O; Department of Preventive and Social Medicine, University of Port Harcourt, Rivers State, Nigeria., Nwadiuto I; Department of Public Health and Disease Control, Rivers State Ministry of Health, Rivers State, Nigeria., Arugu G; Department of Public Health and Disease Control, Rivers State Ministry of Health, Rivers State, Nigeria., Tobin-West C; Department of Preventive and Social Medicine, University of Port Harcourt, Rivers State, Nigeria., Azi E; Department of Community Medicine, Rivers State University Port-Harcourt, Nigeria, Rivers State, Nigeria., Oris-Onyiri V; Department of Public Health and Disease Control, Rivers State Ministry of Health, Rivers State, Nigeria., Urang IJ; Department of Community Health, Rivers State Primary Health Care Management Board, Rivers State, Nigeria., Abikor V; Department of Public Health and Disease Control, Rivers State Ministry of Health, Rivers State, Nigeria., Olofinuka AM; World Health Organization Abuja Office, Abuja, Nigeria., Adebiyi O; Department of Public Health and Disease Control, Rivers State Ministry of Health, Rivers State, Nigeria., Somiari A; Department of Community Medicine, University of Port Harcourt Teaching Hospital, Rivers State, Nigeria., Avundaa H; Department of Community Medicine, University of Port Harcourt Teaching Hospital, Rivers State, Nigeria., Alali A; Department of Community Medicine, University of Port Harcourt Teaching Hospital, Rivers State, Nigeria.
Publikováno v:
The Pan African medical journal [Pan Afr Med J] 2021 Jan 12; Vol. 38, pp. 25. Date of Electronic Publication: 2021 Jan 12 (Print Publication: 2021).
Publikováno v:
The Egyptian Journal of Otolaryngology, Vol 37, Iss 1, Pp 1-7 (2021)
Abstract Background To evaluate the prevalence of olfactory dysfunction (OD) in the Indian population and to establish olfactory dysfunction as a screening tool in COVID-19-positive patients. Data was collected using a questionnaire from laboratory-c
Externí odkaz:
https://doaj.org/article/0a64aa0109e24037bd33b34d8cc679c9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cui L; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China., Li T; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China., Xue W; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China., Zhang S; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China., Wang H; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China., Liu H; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China., Gu Y; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China., Xia N; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China., Li S; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China.
Publikováno v:
Viruses [Viruses] 2024 Jun 01; Vol. 16 (6). Date of Electronic Publication: 2024 Jun 01.
Autor:
Sadidi R; Department of Biology, College of Basic Sciences, Damghan Branch, Islamic Azad University, Damgan, Iran., Ajoudanifar H; Department of Biology, College of Basic Sciences, Damghan Branch, Islamic Azad University, Damgan, Iran., Ghasem Zadeh-Moghadam H; Department of Pathobiology and Laboratory Sciences, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran., Azimian A; Department of Pathobiology and Laboratory Sciences, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Publikováno v:
Iranian journal of medical sciences [Iran J Med Sci] 2024 May 01; Vol. 49 (5), pp. 332-338. Date of Electronic Publication: 2024 May 01 (Print Publication: 2024).
Autor:
Datonye Alasia, Golden Owhonda, Omosivie Maduka, Ifeoma Nwadiuto, Godswill Arugu, Charles Tobin-West, Esther Azi, Victor Oris-Onyiri, Inwon Joseph Urang, Victor Abikor, Ayo-Maria Olofinuka, Obelebra Adebiyi, Abiye Somiari, Hope Avundaa, Alali Aloni
Publikováno v:
The Pan African Medical Journal, Vol 38, Iss 25 (2021)
INTRODUCTION: the knowledge of epidemiologic and clinical variables in patients with SARS- CoV-2 infection provides evidence and lessons that are useful for the pandemic response, with consideration of National and sub-National variations. The object
Externí odkaz:
https://doaj.org/article/f79e5a4716e34b1aad059168e56396d8
SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies.
Autor:
Guo H; IGM Biosciences, Mountain View, CA 94043, USA., Ha S; IGM Biosciences, Mountain View, CA 94043, USA., Botten JW; Department of Medicine, Division of Pulmonary Disease and Critical Care Medicine, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, VT 05405, USA.; Department of Microbiology and Molecular Genetics, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, VT 05405, USA., Xu K; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA., Zhang N; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA., An Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA., Strohl WR; IGM Biosciences, Mountain View, CA 94043, USA., Shiver JW; IGM Biosciences, Mountain View, CA 94043, USA., Fu TM; IGM Biosciences, Mountain View, CA 94043, USA.
Publikováno v:
Viruses [Viruses] 2024 Apr 28; Vol. 16 (5). Date of Electronic Publication: 2024 Apr 28.
Autor:
Yoshifumi Uwamino, Toshinobu Kurafuji, Yasunori Sato, Yukari Tomita, Ayako Shibata, Akiko Tanabe, Yoko Yatabe, Masayo Noguchi, Tomoko Arai, Akemi Ohno, Hiromitsu Yokota, Wakako Yamasawa, Shunsuke Uno, Tomoyasu Nishimura, Naoki Hasegawa, Hideyuki Saya, Masatoshi Wakui, Mitsuru Murata
Publikováno v:
Vaccine
Background SARS-CoV-2 vaccination has started worldwide, including Japan. Although high rates of vaccine response and adverse reactions of BNT162b2 vaccine have been reported, knowledge about the relationship between sex differences and antibody resp